Posted · RFA-CA-27-016
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
National Institutes of Health · HHS
CFDA Numbers
93.395
Award Ceiling
—
Award Floor
—
Expected Awards
6
Close Date
Jun 30, 2026
Section I
How to Apply
Program Contact
NCI ETCTN RFA<br/>Email: NCIETCTNRFA@mail.nih.gov
Email: NCIETCTNRFA@mail.nih.gov
Section II
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Eligible institution/organization for the purposes of this application is defined as an academic center/organization in the United States or Canada providing direct medical care to patients that is considered one integral organizational entity under a single financial management system and governance structure. A center/organization (e.g., an academic hospital and/or academic clinic program) for this application is distinguished from large medical centers whose primary mission is patient care. In addition to patient care, academic centers/organizations have comprehensive medical training programs, investigational pharmacies, advanced imaging facilities, and preclinical laboratories that perform basic research.The only Non-domestic (non-U.S.) Entities (Foreign Institutions) allowed in response to this NOFO are Canadian Institutions.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Eligible Applicant Types
00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25
Section III
Description
Section IV
Key Dates
- Posted
- May 8, 2026
- Closes
- Jun 30, 2026
- Archive
- Aug 29, 2026